↓ Skip to main content

Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making

Overview of attention for article published in Frontiers in Pharmacology, February 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
55 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
Published in
Frontiers in Pharmacology, February 2020
DOI 10.3389/fphar.2020.00043
Pubmed ID
Authors

Robbe Saesen, Stéphane Lejeune, Gianluca Quaglio, Denis Lacombe, Isabelle Huys

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 15%
Student > Master 6 11%
Student > Ph. D. Student 5 9%
Student > Bachelor 3 5%
Lecturer 2 4%
Other 6 11%
Unknown 25 45%
Readers by discipline Count As %
Social Sciences 6 11%
Medicine and Dentistry 5 9%
Biochemistry, Genetics and Molecular Biology 4 7%
Agricultural and Biological Sciences 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Other 11 20%
Unknown 24 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 March 2020.
All research outputs
#16,095,107
of 25,904,557 outputs
Outputs from Frontiers in Pharmacology
#5,459
of 20,045 outputs
Outputs of similar age
#261,528
of 476,023 outputs
Outputs of similar age from Frontiers in Pharmacology
#171
of 466 outputs
Altmetric has tracked 25,904,557 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,045 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 476,023 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 466 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.